Chemical Engineering Magazine has published its second article of the biopharmaceutical manufacturing series, written by Biomanufacturing Engineer, David Gemmell. In the article he explores how chemical engineers play their part in the manufacture of biopharma products from traditional vaccines to new modalities such as mRNA-based therapeutics.
Learn more about modern manufacturing philosophies in the second article of the series, Biopharmaceutical Manufacturing: An Evolving Industry.
David Gemmell has been working for
This collection of insights, produced through a partnership between
In this webinar, join industry experts to learn about strategies to accelerate mRNA therapies and enable scalability and...
Purification efficiency evaluated endotoxin and host cell protein (HCP) clearance, plasmid yield, potential interference of the detergents with...
BioLabs builds innovation communities around Biotech entrepreneurs providing them with infrastructure, support, and networking to successfully succeed. Hear...
Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…
The covid-19 pandemic forced rapid vaccine development and market approval, shortening a process that normally takes years to...
